The QualityStocks Daily Thursday, June 6th, 2019

Today's Top 3 Investment Newsletters

MarketClub Analysis (LJPC) +92.48%

TopPennyStockMovers (SEII) +84.62%

CannabisNewsWire (SGMD) +30.63%

The QualityStocks Daily Stock List

Western Capital Resources, Inc. (WCRS)

Penny Stock Tweets, Marketbeat, 4-Traders, InvestorsHub, Investors Hangout, OTC Markets, Stockhouse, Capital Cube, PR Newswire, Simply Wall St, and Dividend Investor reported beforehand on Western Capital Resources, Inc. (WCRS), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Western Capital Resources, Inc. is a holding company based in Omaha, Nebraska. The Company’s focus is on growing via the acquisition of established lower middle market businesses with up to $100 million in sales. Western Capital Resources’ strategy is to build a diversified portfolio of strong cash flow generating businesses. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Western Capital Resources is industry agnostic. The Company targets leaders in niche industries or geographies, and also opportunistic purchases of businesses that it can improve operationally. It has a particular interest in situations involving companies facing succession dilemmas, corporate divestitures and businesses in out-of-favor industries.

Western Capital Resources’ present holdings include companies in the franchising, retail, as well as consumer finance space. Current holdings include Jackson & Perkins. This is an online and catalog retailer of roses, plants, seeds and holiday gifts. It sells products under the Jackson & Perkins, Wayside Gardens and Park Seed brands, based in Greenwood, South Carolina.

Current holdings also include Van Dyke’s Restorers (Greenwood, South Carolina) an online and catalog retailer selling a broad array of home restoration hardware, decor and furniture; and ExpressPawn - an operator of three pawn locations in Iowa and Nebraska, based in Omaha, Nebraska.

Furthermore, current holdings include PQH Wireless a dealer for Cricket Wireless operating roughly 280 retail locations in 29 states as of August 30, 2017, based in Omaha, Nebraska; and Wyoming Financial Lenders, an operator of 40 retail locations providing consumer finance services in seven states, headquartered in Omaha.

Western Capital Resources invests in established companies - no start-ups, early stage or distressed businesses. The Company’s focus is on basic industries. These include but are not limited to manufacturing, distribution, business services, multi-unit retail, e-commerce, consumer, and franchising. It does not invest in restaurants or hi-technology businesses.

The Company has a full-time integrated acquisitions team centered on sourcing, evaluating, financing, as well as completing new acquisitions. The majority of business, industry and financial due diligence is performed in-house.

Western Capital Resources, Inc. (WCRS), closed Thursday's trading session at $3.85, even for the day, on 1,000 volume with 1 trade. The average volume for the last 3 months is 971 and the stock's 52-week low/high is $3.00/$5.00.

chart

Cardiol Therapeutics, Inc. (CRTPF)

Stock Gumshoe, OTC Markets, Cannabis FN, NIC Investors, Stock Target Advisor, Invest Tribune, Growstox, Market Screener, Investing News, Stockhouse, and Investorx reported earlier on Cardiol Therapeutics, Inc. (CRTPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A biotechnology company, Cardiol Therapeutics, Inc. specializes in the research and commercial development of novel drug therapies utilizing proprietary drug-delivery systems. The Company is a leader in the research and commercial development of pharmaceutical CBD and targeted therapies for inflammatory diseases. Cardiol is leveraging its expertise in pharmaceutical CBD to develop ultra-pure CBD products for commercialization in the billion dollar market for medicinal cannabinoids in Canada. Incorporated in 2017, and OTCQX-listed, Cardiol Therapeutics is headquartered in Oakville, Ontario.

The Company has a view to expanding into Latin America and Europe, and to utilizing nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs for the treatment of heart failure. It is taking advantage of its expertise in pharmaceutical cannabinoids to develop proprietary formulations for commercial development in three important medical markets.

These include commercializing a line of pharmaceutically-manufactured pure cannabidiol products in the growing market for medical cannabinoids, developing nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs for the treatment of heart failure; and pursuing an immunotherapeutics program starting with a unique cancer immunotherapeutic in combination with cannabinoids for Glioblastoma Multiforme, a Fast Track eligible orphan indication.

The design of Cardiol’s proprietary nanotherapeutics are to increase the compatibility of drugs with the aqueous blood circulation, improve pharmacokinetics, and facilitate drug accumulation in the failing heart. The Company is also commercializing a line of pharmaceutically-manufactured pure cannabidiol products to address the increasing market for medical cannabinoids. In collaboration with Dalton Pharma Services, Cardiol Therapeutics is developing innovative manufacturing expertise in the production of pharmaceutical cannabinoids in support of its nanotherapeutics program in heart failure.

Cardiol Therapeutics’ nanotherapeutics are based on a patented family of biocompatible and biodegradable amphiphilic block co-polymers made from polyethylene glycol (PEG) and polycaprolactone (PCL). PEG and PCL have a long history of safe use in humans. The Company’s proprietary nanoparticles have improved inherent stability and biocompatibility. In addition, they can be customized to optimize the encapsulation and release characteristics of a wide spectrum of pharmaceuticals.

Cardiol Therapeutics, Inc. (CRTPF), closed Thursday's trading session at $3.63189, up 14.21%, on 13,546 volume with 73 trades. The average volume for the last 3 months is 29,003 and the stock's 52-week low/high is $2.52/$10.00.

chart

ImageWare Systems, Inc. (IWSY)

Street Insider, Wallet Investor, Marketbeat, Simply Wall St, InvestorsHub, Wallmine, 4-Traders, Stockopedia, TipRanks, Super Stock Screener, Equity Clock, Insider Financial, Zacks, Market Screener, and Insider Tracking reported previously on ImageWare Systems, Inc. (IWSY), and today we report on the Company, here at the QualityStocks Daily Newsletter.

ImageWare Systems, Inc. is a leader in mobile and cloud-based, multi-modal biometric identity management solutions. The Company provides two-factor, biometric and multi-factor cloud-based authentication solutions for the enterprise. ImageWare serves healthcare, banking, retail/e-commerce, government, and also law enforcement and public safety markets. ImageWare Systems is headquartered in San Diego, California. The Company also has offices in Oregon, Canada, Mexico, and Japan.

ImageWare Systems delivers next-generation biometrics as an interactive and scalable cloud-based solution. It brings together cloud and mobile technology to offer two-factor, biometric, and multi-factor authentication for smartphone users, for the enterprise, and across industries. The Company’s products support multi-modal biometric authentication including, but not limited to, face, voice, fingerprint, iris, palm, and more.

All of the biometrics can be combined with or used as replacements for authentication and access control tools (including tokens, digital certificates, passwords, and PINS) to provide the supreme level of assurance, accountability, and user-friendliness for corporate networks, web applications, mobile devices, and PC (Personal Computer) desktop environments.

Recent significant events for ImageWare Systems include introducing the ImageWare Digital Identity Platform ™. This is an end-to-end digital biometric identity proofing, authentication and lifecycle management solution. This platform provides the widest set of identity validation and biometric authentication capabilities in the industry.

In February, ImageWare entered into a definitive agreement with an international financial services provider to provide multi-modal biometric authentication solutions for a healthcare application. In March, Contactable (Pty) Ltd. informed ImageWare that it was awarded a contract to provide onboarding, identity proofing, digital identity and biometric authentication services to a major multinational mobile telecommunications company. Contactable will be providing the mobile telecommunications company with ImageWare’s multi-modal Biometric Engine for the biometric authentication. Contactable is a reseller of ImageWare’s identity and biometric authentication services and products.

Last month, ImageWare Systems reported financial results for Q1 ended March 31, 2019. Revenue for the quarter ended March 31, 2019 increased 30 percent to $931,000 from $716,000 in Q1 2018. Gross Profit for Q1 2019 was $727,000 (78 percent) versus $468,000 (65 percent) in Q1 2018. Net Loss was $3.6 million in Q1 2019 versus $3.6 million in Q1 2018.

ImageWare Systems, Inc. (IWSY), closed Thursday's trading session at $1.00, off by 8.42%, on 137,449 volume with 66 trades. The average volume for the last 3 months is 146,562 and the stock's 52-week low/high is $0.55/$1.79.

chart

Alkane Resources Limited (ANLKY)

StreetWise Reports, Penny Stock Hub, InvestorIntel, Connecting Investor, OTC Markets, Wallmine, InvestorsHub, and Wallet Investor reported previously on Alkane Resources Limited (ANLKY), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Alkane Resources Limited is a gold production company with a multi-commodity exploration and development portfolio. The Company is presently focused on gold exploration, production and investment. Alkane has projects and operations situated in the Central West of New South Wales, eastern Australia. The Company is also a gold producer by way of its wholly-owned subsidiary, Tomingley Gold Operations (TGO). OTCQX-listed, Alkane Resources has its corporate office in Burswood, Australia.

The Company also maintain offices and operations in eastern Australia. This includes Narromine Shire – home of its producing gold mine, Tomingley Gold Operations and its highly prospective tenement package. Alkane also has an office in Parkes Shire – home of its Peak Hill Gold Mine and further exploration tenements. Moreover, it has an office in Dubbo Regional Council LGA – home of its world-class, construction-ready, multi-commodity Dubbo Project.

Alkane’s most significant project is the Dubbo Project, owned by Alkane subsidiary, Australian Strategic Materials (ASM), that stands to become a strategic and significant world producer of zirconium, certain rare earths, hafnium and niobium. The Dubbo Project has a potential mine life of 70+ years. It is the most advanced project of its type outside China.

The gold operations at Tomingley are about 50 kilometers south-west of Dubbo in Central West NSW. Operated by Tomingley Gold Operations (TGO), the wholly-owned subsidiary of Alkane Resources, the gold processing plant was commissioned on time and on budget in January 2014. It has been operating at the design capacity of 1Mtpa from early 2014.

Mining at Tomingley is based on four gold deposits (Wyoming One, Wyoming Three, Caloma and Caloma Two.) Open cut mining occurred on the deposits until early this year producing 60,000 to 80,000 ounces of gold per year. Underground mining started in early 2019 from the bottom of the Wyoming One pit.

Alkane Resources has executed a binding agreement with Ziron Tech to fund the final stage research and feasibility in relation to a clean metal process. The South Korean company has developed technology in the form of a carbon-free process to convert metal oxides into metals via an electrolytic process.

With this deal, Alkane Resources will invest US$1.2 million towards a pilot plant facility to complete late-stage piloting and feasibility study for larger scale development and commercialization of the process. This technology could provide a cost-effective and environmentally superior alternative to the traditional Kroll process used to make high purity zirconium, hafnium, and titanium metals. This has the potential to boost the value of the 100 percent-owned Dubbo Project in New South Wales.

Alkane Resources Limited (ANLKY), closed Thursday's trading session at $2.26, up 2.73%, on 14,167 volume with 11 trades. The average volume for the last 3 months is 567 and the stock's 52-week low/high is $1.29/$2.49.

chart

Bonterra Resources, Inc. (BONXF)

Proactive Investors, Minestat, Stock Junction, MiningFeeds, Stockwatch, Wall Street Nation, Investing News, Stockhouse, and Junior Mining Network reported earlier on Bonterra Resources, Inc. (BONXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bonterra Resources, Inc. is a gold exploration company based in Val-d’Or, Québec. The Company has a large balanced portfolio of exploration and mining assets including the Gladiator, Barry and Moroy deposits, Urban-Barry Mill and multiple highly prospective exploration prospects. Incorporated in 2007, Bonterra Resources lists on the OTC Markets Group’s OTCQX.

The Company controls the only permitted gold mill in the region with a large land position of roughly 20,815 hectares in the Urban Barry Camp. Bonterra is located in the mining-friendly province of Québec, within the Abitibi Greenstone Belt.

The Urban-Barry Mill is connected to the provincial power grid, has high-speed Internet and cell phone service with an all-season camp for workers. Bonterra Resources’ plan is to expand the existing mill to 2,400 tonnes per day by the second half of this year.

The Gladiator Deposit is a highly silicified and altered sheared mafic volcanics, locally exhibiting intrusions of syenite and quartz porphyry. Smoky quartz veining also occurs locally containing the bulk of the mineralization and free gold. Mineralization at the Company’s Barry Deposit has been identified 1,300 m along strike and 600 m at depth. The deposit remains open in all directions, where a minimum of three distinct sub-parallel gold bearing shear zones and secondary tension veins are mineralized.

The Moroy Deposit is a south-parallel system to the Bachelor mine dipping north towards the Bachelor trend with potential to intersect the main trend at depth. Development and drill programs are taking place at Moroy with over 65,000 m of surface and underground drilling completed to date. This year, Bonterra will update the NI 43-101 mineral resource estimate at the Moroy Deposit. Moreover, Bonterra has regional exploration at the Bart Zone, the Coniagas Zone, the Moss Zone, and the St. Cyr Zone.

Recently, Bonterra Resources provided an update of its activities on its advanced exploration projects in the Urban-Barry Camp near Val-d'Or, Québec. It completed 15,947 meters of infill and exploration diamond drilling during the quarter ended February 28, 2019. Four drill rigs are now active on the Gladiator, Barry and Moroy projects. It has retained the services of SGS Geostat to complete an NI 43-101 resource estimate and technical report on three deposits.

Furthermore, Bonterra Resources is nearing completion on an environmental impact assessment for the Urban-Barry mill expansion from 800 to 2,400 tonnes per day. The Company has also engaged two engineering firms, one commissioned to design the mill expansion, and one to increase the capacity of the tailings storage facility to 10 million tonnes.

Last week, Bonterra Resources announced results of the recently completed NI 43-101 Mineral Resource Estimates for the Gladiator, Barry, and Moroy deposits located in the Urban-Barry Camp. Highlights of the Mineral Resource Estimates for Gladiator include Indicated Resources of 743,000 tonnes at an average grade of 8.46 grams per tonne Au totaling 202,000 ounces Au.; and Inferred resources of 3,065,000 tonnes at an average grade of 9.10 grams per tonne Au totaling 897,000 ounces Au.

Bonterra Resources, Inc. (BONXF), closed Thursday's trading session at $1.388, up 3.24%, on 10,651 volume with 13 trades. The average volume for the last 3 months is 12,496 and the stock's 52-week low/high is $0.223/$2.87.

chart

Exactus, Inc. (EXDI)

NetworkNewsWire, Stock Guru, Zacks, Finance Recorder, GlobeNewswire, All Cap Research, OTC Presswire, Proactive Investors, GuruFocus, Market Exclusive, Trading View, and Stockwatch reported on Exactus, Inc. (EXDI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Exactus, Inc. is a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products. It sells its CBD products by way of its Exactus brand and white label products to third-party resellers. Furthermore, Exactus engages in producing industrial hemp from farms in Oregon. Also, it plans to extract and manufacture directly through cGMP facilities. Exactus has its corporate office in Delray Beach, Florida. The Company lists on the OTCQB.

Exactus One World is the name of the Exactus farming and production initiative. The seeds (genetics) used at Exactus One World are sourced from Oregon CBD, founded by Seth and Eric Crawford. They are thought to be one of the world's foremost breeding, research and production facilities for CBD seed. Exactus farms and processes industrial hemp to be manufactured into cannabidiol (CBD) related products using, as much as possible, their facilities and cGMP resources at every step of the supply chain.

Exactus entered into a Master Product Development and Supply Agreement with Ceed2Med this past January. Ceed2Med utilizes cGMP facilities and with this Agreement, Exactus has been allotted a minimum of 50 and up to 300 kilograms per month, and up to 2,500 kilograms annually, of active phyto-cannabinoid (CBD) rich ingredients for resale. Exactus offers tinctures, edibles, capsules, as well as topical solution products manufactured for use by Ceed2Med.

Moreover, Exactus’ Point-of-Care diagnostic tools will use patented technology to analyze biometric markers in a single drop of blood. This will reveal important insights into patient health. The FibriLyzer™ is intended to provide a simple and affordable solution to assess the fibrinolytic status of patients in a wide array of applications. The Company believes the FibriLyzer™ could provide the foundation for improved management of patients who are at-risk of uncontrolled bleeding.

FibriLyzer™ uses a disposable test biosensor strip combined with a portable hand held detection unit for the management of hyperfibrinolytic states associated with surgery and trauma, obstetrics, acute events, and pulmonary embolism and deep vein thrombosis, and also for use in chronic coronary disease management.

The MatriLyzer™ will undergo development to detect the initial occurrence or the recurrence of cancer during routine office visits. The appearance of elevated levels of collagenase, the enzyme that degrades collagen, have been proven to be an early hallmark of cancer.

                   

Exactus, Inc. (EXDI), closed Thursday's trading session at $1.05, up 10.53%, on 25,695 volume with 15 trades. The average volume for the last 3 months is 12,885 and the stock's 52-week low/high is $0.048/$4.00.

chart

Kraig Biocraft Laboratories, Inc. (KBLB)

Investor Village, StockPulse, TipRanks, Discovery Stocks, Emerging Growth, Stockhouse, Wallet Investor, Super Stock Screener, Infront Analytics, InvestorsHub, Insider Financial, Simply Wall St, and Trading View reported previously on Kraig Biocraft Laboratories, Inc. (KBLB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Kraig Biocraft Laboratories, Inc. is the top developer of genetically engineered spider silk based fibers. The Company has realized a series of scientific breakthroughs in the area of spider silk technology with implications for the international textile industry. Its genetic engineering research has succeeded in developing what many consider to be the holy grail of material science – a practical and cost-effective technology for producing recombinant spider silk based fibers on an industrial scale. Kraig Biocraft Laboratories is based in Ann Arbor, Michigan and lists on the OTC Markets’ OTCQB.

Spider Silk is among the strongest fibers produced in nature. Some spider species can produce up to seven different types of silk depending upon the spider’s particular need at that time. Spider silk holds the potential of a lifesaving ballistic resistant material - lighter, thinner, flexible and hardier than steel material.

Kraig Biocraft Laboratories obtained at its inception, proprietary genetic engineering technology to unlock the mystery of producing spider silk. In early 2006, the Company obtained certain exclusive rights from the University of Wyoming to use the spider silk gene sequences in its field of use. Currently, it is ramping up production of its Monster Silk™ and Dragon Silk™ for commercialization. Moreover, it is continuing to develop new and recombinant spider silk fibers.

Polartec and Kraig Biocraft Laboratories announced this past April plans to bring to market the first fabrics made from spider silk. Initially developed for specialized military applications, these first-of-their-type materials made from recombinant spider silk will ultimately service the global market for high performance textiles and apparel. Polartec is the premium provider of innovative and sustainable textile solutions.

Last week, Kraig Biocraft Laboratories announced the creation of the next generation of recombinant spider silk using the Company’s new design, gene editing, and incorporation approaches. Kraig Labs designed this approach to customize mechanical properties for specific commercial markets. It has demonstrated the ability to more quickly, accurately, and efficiently, generate new transgenics.

Mr. Jon Rice, Chief Operating Officer, said, “This breakthrough has powerful ramifications that affect the core of how we develop future spider silk materials. These newly confirmed transgenics mark a revolutionary advancement in capability of our spider silk materials. The new tools developed by Dr. Trevor Kane and our research team will allow us to target commercial markets that were not originally on our radar.”

This week, Kraig Biocraft Laboratories announced that, in recognition of the magnitude of numerous recent achievements, Dr. Trevor Kane has been promoted to the position of Chief Scientist. Dr. Kane’s successes in creating new transgenics in the lab and expanding the Company’s intellectual property (IP) portfolio with many new provisional patent applications, mark a significant milestone and advancement in Kraig Labs mission to produce and commercialize eco-friendly materials that surpass the performance and strength of native spider silk.

Kraig Biocraft Laboratories, Inc. (KBLB), closed Thursday's trading session at $0.281, off by 2.77%, on 2,040,410 volume with 197 trades. The average volume for the last 3 months is 4,671,089 and the stock's 52-week low/high is $0.0352/$0.507.

chart

Gold Reserve, Inc. (GDRZF)

Savvy Trader Resource, The Otc Reporter, Barchart, Business Wire, Equities, InvestorsHub, Investors Hangout, Super Stock Screener, 4-Traders, The Street, Stockhouse, OTC Markets, MarketWatch, Otc. Watch, GuruFocus, and Morningstar reported earlier on Gold Reserve, Inc. (GDRZF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

OTCQX-listed, Gold Reserve, Inc. acquires, explores, and develops mining projects. The Company has a history in mining dating back to 1956 and established for the purpose of acquiring, exploring, and developing mining properties and placing them into production. An exploration stage enterprise, Gold Reserve is headquartered in Spokane, Washington.

The Company’s goal to successfully develop proven and probable reserves through making selective property and/or corporate acquisitions. In 1992, Gold Reserve acquired and started developing what is now known as the Brisas gold and copper project in the historic Km 88 mining district of the State of Bolivar in southeastern Venezuela. The Brisas deposit contains ore reserves of 10.2 million ounces of gold and 1.4 billion pounds of copper.

Gold Reserve announced in 2018 that the mixed company Empresa Mixta Ecosocialista Siembra Minera S.A. (SM), owned 45 percent by Gold Reserve and 55 percent by the Bolivarian Republic of Venezuela, received the Permit to Effect for the Siembra Minera Gold Copper Project (SM Project) from the Venezuelan Ministry of the Environment. The Permit to Effect permits site clearing, construction of a temporary camp and warehouse facilities, drilling of dewatering and development drill holes, construction of access roads on the property, and opening of the quarry for construction aggregates.

Gold Reserve completed a positive NI-43-101 compliant Preliminary Economic Assessment (PEA) on the Siembra Minera project in 2018. It also completed preliminary design and cost estimates and related tailings dam facilities for the Small Plant. In addition, the Company began activities associated with the preparation of a Venezuela Environment Impact Statement (VEIS) and International Environmental and Social Impact Assessment (IESIA), collected a surface saprolite material sample for transport to the U.S. for metallurgical testing and acquired the permit to effect the environment for the Siembra Minera Project (Permit to Effect) from the Venezuelan Ministry of the Environment.

Last week, Gold Reserve reported that it presently has a cash balance of $167 million (including $21.5 million held in Bandes Bank and from the sale of Venezuelan sovereign debt received last year) with current liabilities of about $3 million. The Company’s Board of Directors decided to distribute to shareholders a minimum of $90 million with the final distribution amount and method (that may require shareholder and/or regulatory approvals) to be determined by the Board in the coming weeks.

Gold Reserve, Inc. (GDRZF), closed Thursday's trading session at $2.48, up 3.33%, on 35,649 volume with 29 trades. The average volume for the last 3 months is 7,071 and the stock's 52-week low/high is $1.84/$3.02.

chart

United Cannabis Corp. (CNAB)

Stockgoodies, Cannabis Financial Network News, Stocks Impossible, Priceless Penny Stocks, Market Intelligence, Wall Street Wolves, Promotion Stock Secrets, Wealth Insider Alert, Wall Street Mover, Marketbeat, StreetAuthority Daily, Actual Gains, Broad Street, TopPennyStockMovers, PennyStockRumors, Money Map Press, and MyBestStockAlerts reported previously on United Cannabis Corp. (CNAB), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter. 

United Cannabis Corp.’s dedication is to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. The Company formed to provide leadership in the medical cannabis industry. This is through providing patient driven solutions intent on improving biomedical and pharmaceutical pursuits using cannabis-based research, products, as week as services.

A biotechnology company, United Cannabis is headquartered in Denver, Colorado. United Cannabis has a majority share of Prana Therapeutics, Inc. (PTI). PTI is a clinical stage biotechnology company developing Polymolecular Botanical therapeutics for the oncology, neurology, and orthopaedic markets.

United Cannabis provides consulting services, proprietary products, and licenses its intellectual property (IP) to businesses in the cannabis industry. United Cannabis owns distinct IP relating to the legalized growth, production, manufacture, marketing, management, use and distribution of medical and recreational marijuana and marijuana infused products. It is the creator of Prana Bio Nutrient Medicinals. Its A.C.T. Now Program and Prana Bio Nutrient Medicinals provide a total solution designed to enable physicians and patients to implement and monitor effective therapy protocols.

Prana Bio Nutrient Medicinals is a complete, full spectrum cannabinoid system. It uses the whole cannabis plant through controlling specific cannabinoid ratios, accurate dosing, and numerous non-abrasive delivery methods.

The A.C.T. Now program provides nutritional recommendations These recommendations are to help patients suffering from chronic pain, opiate dependency, inflammation, glaucoma, PTSD, neuropathy, multiple sclerosis (MS), fibromyalgia, Crohn’s, IBS, seizures, epilepsy, paralysis, autoimmune, autism, tumors, HIV/AIDS, and many kinds of cancer.

Last month, United Cannabis announced that it entered into a Joint Venture (JV) with Blue Water Green Bridge, LLC a South Carolina company, to create an industrial hemp processing plant. The new venture is called Magnolia Botanicals LLC.

Mr. Earnest Blackmon, United Cannabis’ Chief Executive Officer, said, ''The Company's successful expansion into Colorado's industrial hemp sector was the impetus for us to seek other regions where market demand was not being met and our expertise could provide value. Working in conjunction with Blue Water not only gives us a foothold in the South East's burgeoning industrial hemp market, it also provides us with a strong financial partner.''

United Cannabis Corp. (CNAB), closed Thursday's trading session at $0.3601, down 0.52%, on 91,254 volume with 53 trades. The average volume for the last 3 months is 238,990 and the stock's 52-week low/high is $0.30/$1.00.

chart

AmeriCann, Inc. (ACAN)

NetworkNewsWire, SmallCapVoice, TheMicrocapNews, Dividend Investor, last10k, OTC Markets Group, Real Pennies, TopPennyStockMovers, Promotion Stock Secrets, and Cannabis Financial Network News reported earlier on AmeriCann, Inc. (ACAN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AmeriCann, Inc. is developing sustainable, state-of-the-art, medical cannabis cultivation properties. The Company is a national leader of sustainable cultivation and processing infrastructure for the medical marijuana industry. OTCQB-listed, AmeriCann designs, builds, and owns efficient cultivation and processing facilities to produce medical cannabis. It is developing projects across the nation in regulated markets via the “Preferred Partner Program”. An Agricultural Technology Company, AmeriCann is based in Denver, Colorado.

AmeriCann identifies, acquires, and also develops real estate especially suited for cannabis operations. It finances real estate development. In addition, the Company provides necessary venture capital to developing cannabis businesses.   

AmeriCann is developing a 53-acre property in Massachusetts as the Massachusetts Medical Cannabis Center (the MMCC). The MMCC has approval for close to 1 million square feet. The expectation is that it will be one of the most technologically advanced cultivation facilities in the nation. AmeriCann has agreements with Coastal Compassion, Inc. (CCI), its Preferred Partner in Massachusetts, to lease 100 percent of the initial phase of MMCC.  
 
AmeriCann has its Preferred Partner in Massachusetts, Bask, Inc. (BASK of BASK Premium Cannabis). In 2016, AmeriCann formed an alliance with BASK as a Preferred Partner in Massachusetts. BASK is scheduled to be the first business to operate in AmeriCann's Massachusetts Medical Cannabis Center (MMCC). BASK is an established Massachusetts cannabis operator.

Recently, AmeriCann provided a construction update for its flagship Massachusetts Medical Cannabis Center (MMCC). Construction of the MMCC project is moving ahead quickly. Million of dollars have already been invested in site preparation, concrete, as well as steelwork. Over a dozen companies have been retained for construction of the facility that is being supervised by CBRE on behalf of AmeriCann.

The construction of Building 1, which is a 30,000 square foot cultivation and processing facility, is scheduled for completion this summer. The entire building will be 100 percent leased by an existing, vertically-integrated Massachusetts operator, Bask, Inc.

In February, AmeriCann announced that it executed a definitive agreement for the terms of a Joint Venture (JV) with Bask, Inc. at AmeriCann’s Massachusetts Medical Cannabis Center (MMCC). The MMCC is undergoing development on a 52-acre parcel in Southeastern Massachusetts. The MMCC project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure that will be developed in phases and plans to support the existing medical cannabis and the newly emerging adult-use cannabis market. AmeriCann’s plan is to replicate the brands, technology and innovations developed at its MMCC project to new markets as a licensed multi-state operator (MSO).

AmeriCann, Inc. (ACAN), closed Thursday's trading session at $1.12, up 2.75%, on 82,753 volume with 97 trades. The average volume for the last 3 months is 39,514 and the stock's 52-week low/high is $0.81/$3.97.

chart

Noble Roman’s, Inc. (NROM)

Simply Wall St, Taglich Brothers, SmallCapVoice, Insider Financial, Marketbeat, The Bowser Report, Wallet Investor, FeedBlitz, Equity Clock, Penny Stock Tweets, Stockopedia Penny Stock Hub, Investor Village, Tip Ranks, Stock Oodles, Wall Street Resources, YCharts, and MicroCapClub reported earlier on Noble Roman’s, Inc. (NROM),  and today we are reporting on the Company, here at the QualityStocks Daily Newsletter. 

Noble Roman's, Inc. sells and services franchises and licenses for non-traditional foodservice operations and stand-alone take-n-bake locations. The Company’s business model consists of three growth venues. These are Grocery Take-n-Bake Licensing; Non-Traditional Franchising; and Stand-Alone Franchising. The Company franchises and licenses under the Noble Roman’s Pizza, Noble Roman’s Take-N-Bake, Tuscano’s Italian Style Subs, and Noble Roman's Craft Pizza & Pub (CPP) trade names. Noble Roman’s is headquartered Indianapolis, Indiana.

The Company has awarded franchise and/or license agreements in all 50 U.S. States plus Washington, D.C. In addition, Noble Roman’s has awarded franchise and/or license agreements in Canada, Puerto Rico, the Bahamas, Italy, and the Dominican Republic.

Concerning the Company’s three growth venues,  Grocery Take-n-Bake Licensing involves licensing to sell Noble Roman’s Pizza. This is a component program using Noble Roman’s ingredients, in which delis assemble pizzas from standard Noble Roman’s ingredients.

Pertaining to Stand-Alone Venues, these are traditional pizzeria locations and Take-n-Bake locations. There is a merging over time between the kinds of Stand-Alone Venues: Live Yeast Dough; Hand-Rolled Breadsticks; and Baking Services.

Regarding Non-Traditional Venues, these are typically located in a host facility whose chief business is other than foodservice. These facilities can add pizza-focused foodservice as a Revenue Center; as a Facility Draw; and as an Employee Benefit.

On January 31, 2017, the first Noble Roman's Craft Pizza & Pub (CPP) opened in Westfield, Indiana. In May of 2018, the Company announced that it opened a fourth location of its new-generation, stand-alone pizzeria concept, Noble Roman's Craft Pizza & Pub (CPP) in Carmel, Indiana.

Noble Roman’s intention is to expedite the development of Craft Pizza & Pub (CPP) locations via franchising. General franchising is planned for Indiana and surrounding areas with an emphasis on franchisees that can become multi-unit operators. Moreover, the Company will also pursue development of other markets deemed suitable for the concept with experienced multi-unit operators.

In January, Noble Roman's announced that it completed the roll-out of its new curbside carry-out service in all restaurant locations. The design of the Company's new curbside service for carry-out customers is to create added value and convenience. The program is called "Pizza Valet Service." With Pizza Valet Service, customers place orders ahead, drive into the restaurant's reserved valet parking spaces, and have their pizza run to their vehicle by specially uniformed pizza valets.

Additionally, in January, Noble Roman's announced that its first franchisees for Craft Pizza & Pub (CPP), Patrick and Holly O'Neil, signed a lease and entered into a construction contract for their first CPP restaurant in Lafayette, Indiana. Construction is now taking place. This location is scheduled for a grand opening by late March.

Noble Roman’s, Inc. (NROM), closed Thursday's trading session at $0.65, up 8.33%, on 20,692 volume with 8 trades. The average volume for the last 3 months is 16,382 and the stock's 52-week low/high is $0.33/$0.745.

chart

Integrated Cannabis Company, Inc. (ICNAF)

Awesome Penny Stocks, Market News Updates, Wallet Investor, Trading View, The Venture Report, Market Chameleon, BioSpace, Wallstreet Online, Investors Hangout, MarketWatch, InvestorsHub, Stockwatch, Stockhouse, OTC Markets, CannaBizNetwork, and Barchart reported previously on Integrated Cannabis Company, Inc. (ICNAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Integrated Cannabis Company, Inc.’s focus is health and creating health and lifestyle products utilizing advanced delivery systems and formulations. The Company comprises dedicated scientists and product engineers. It was previously known as CNRP Mining, Inc. It changed its name to Integrated Cannabis Company, Inc. in June of last year. Integrated Cannabis Company is based in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s X-SPRAYS™ product line consists of eight market ready orally ingested spray products. Four products available are infused with hemp-based cannabidiol (CBD). Four products are formulated without a cannabidiol (CBD) infusion.

The products are highly bioavailable; the active ingredients in the sprays are already completely dissolved. Therefore, the vitamins and minerals do not need to be further broken down once swallowed. They are immediately available for use by the body.

The X-SPRAYS™ product line is packaged in precise, metered dose and convenient spray tubes. This includes a child-resistant version. Integrated Cannabis Company’s products are made in Arizona. Its CBD is hemp derived from Colorado.

In September 2018, Integrated Cannabis Company announced the completion of a market ready Tetrahydrocannabinol (THC)-infused spray product and the required licensure for manufacturing of the product in the State of Colorado. The THC product uses the same nanotechnology used to enhance the CBD-infused X-SPRAYS™. This results in higher bioavailability and quicker uptake in comparison to capsules or powder.

Recently, Integrated Cannabis Company announced that X-SPRAYS™ successfully exhibited at the 2019 Athens Cannabis Expo in Greece in January at the Tae Kwon Do Convention Center in Athens, Greece. The Expo took place January 11-13, 2019 in Athens. It attracted industry leaders from across the European Union (EU) and other parts of the world.  X-SPRAYS™ was on display and the Company’s sales team successfully educated the public on their novel formulations and delivery method.

Mr. John Knapp, Integrated Cannabis Company’s Chief Executive Officer, said, “The Athens Cannabis Expo was an excellent opportunity for X-SPRAYS™ to network with EU cannabis businesses and to expand our European distribution channels.The European market showed us great promise in 2019 for CBD products. We are positioning ourselves to take full advantage of the changing landscape this year and believe Europe will be a pivotal component for our growth.”

Integrated Cannabis Company, Inc. (ICNAF), closed Thursday's trading session at $0.265, up 2.32%, on 18,067 volume with 28 trades. The average volume for the last 3 months is 87,948 and the stock's 52-week low/high is $0.1958/$1.58.

chart

SusGlobal Energy Corp. (SNRG)

Simply Wall St, Penny Stock Hub, Trading View, Wallstreet Online, Market Screener, Dividend Investor, Barchart, Investors Hangout, Stocks News Feed, GuruFocus, Street Insider, Interactive Brokers, Law Insider, last10k, YCharts, Morningstar, and MarketWatch reported on SusGlobal Energy Corp. (SNRG), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

SusGlobal Energy Corp. is the developer of SusGro™, which is a pioneering pathogen free organic fertilizer. The Company is a renewables business centered on acquiring, developing, and monetizing a portfolio of proprietary technologies in the waste to energy and regenerative products application worldwide. SusGlobal Energy has its head office in Toronto, Ontario. The Company lists on the OTC Markets Group’s OTCQB.

SusGlobal Energy has the capability to provide a complete range of services for handling organic residuals. The Company has spent years attaining proprietary processes and combining different treatments. It also has many years of innovative experience and technical knowledge and thus can provide its clients with comprehensive solutions. SusGlobal Energy has projects in Belleville, Ontario; Hamilton, Ontario; and Florida.

SusGlobal Energy can, from beginning to end, offer in-depth knowledge, abundant experience and trailblazing technology for all a client’s needs in handling organic waste. Some of the Company’s work managing organic waste streams includes Anaerobic Digestion, Dry Digestion, Biogas Production, Wastewater Treatment, In-Vessel Composting, Source Separated Organics Treatment, Biosolids Heat Treatment and Composting.

The Company’s SusGro™ pathogen free organic fertilizer offers an economical, sustainable and highly effective alternative to traditional fertilization. SusGro™ is an organically-based, concentrated organic pathogen free liquid fertilizer product. It has a full complement of nutrients suitable for a broad spectrum of fertilization requirements.

In addition, SusGlobal Energy’s Earth’s Journey™ Compost enhances plant growth. The Company employs patented technology to transform organic waste into the most nutrient-rich organic compost, diverting organic waste from landfills and lessening Greenhouse Gas (GHG) emissions.

This week, SusGlobal Energy announced that its wholly-owned subsidiary, SusGlobal Energy Belleville Ltd. (SusGlobal Belleville), executed a non-binding Letter of Intent (LOI) for certain assets, including 39.44 acres of property located at 704 Phillipston Road, in Belleville, Ontario. Subject to the execution of an Asset Purchase Agreement (APA), the LOI sets out the terms, including the purchase price of USD$1,332,153 (CAD$1,767,250) in cash to be paid on closing, minus the sum of USD$54,274 (CAD$72,000) advanced by SusGlobal Energy to the seller on February 5, 2019.

If the APA is signed, SusGlobal Belleville will become the owner of the 39.44 land parcel and no more a lessee of the existing 13.88-acre section. SusGlobal Belleville will be expanding the site capacity to 70,000 tonnes per annum from the present 35,000 tonnes per annum composting facility to continue producing its Earth's Journey™ Compost, with an additional 50,000 tonnes per annum organic processing and transfer site approved under the existing Environmental Compliance Approval (ECA) and Site Plan.

Mr. Marc Hazout, Executive Chairman and President of SusGlobal Energy, stated, "We are very pleased to be able to enter into an LOI to purchase this large parcel of land with the ECA attached in order to expand our Belleville site to bring the Ontario, Quebec and New York State organic waste management systems to a sustainable level by diverting from landfills."

SusGlobal Energy Corp. (SNRG), closed Thursday's trading session at $0.30, up 3.45%, on 24,344 volume with 7 trades. The average volume for the last 3 months is 30,509 and the stock's 52-week low/high is $0.15/$5.00.

chart

Nano One Materials Corp. (NNOMF)

NetworkNewsWire, Private Capital Newswire, Charts and Trends, Penny Stock Tweets, Stockhouse, Insider Tracking, Wallmine, Central Charts, GuruFocus, Dividend Investor, MarketWatch, Investors Hangout, OTC Markets, Market Screener, Capital Cube, Wallet Investor, Canadian Insider, Barchart, 4-Traders, and Morningstar reported earlier on Nano One Materials Corp. (NNOMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nano One Materials Corp. is developing patented technology for the low-cost production of high-performance battery materials used in electric vehicles, energy storage and consumer electronics. The Company’s mission is to establish its patented technology as a top platform for the worldwide production of a new generation of nanostructured composite materials. Nano One Materials has its headquarters, laboratory, and pilot facility in Burnaby, British Columbia and also has an office in Vancouver, British Columbia.

At present, the Company has active contribution agreements with the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), Sustainable Development Technology Canada, and the Automotive Supplier Innovation Program – all programs of the Government of Canada. En bloc, these funding sources are projected to extend Nano One’s operating capital into Q1 2020.

The processing technology addresses important supply chain constraints through enabling wide-ranging raw materials specifications for use in lithium ion batteries. The process can be configured for a range of diverse nanostructured materials. Furthermore, it has the flexibility to shift with developing and future battery market trends and a varied range of other growth opportunities.

The novel three-stage process utilizes equipment common to industry. Nano One Materials has constructed a pilot plant to demonstrate high volume production and to optimize its technology across a range of materials. The core technology assembles low-cost raw materials in solution (including lithium, cobalt, magnesium) at high rates of production, before industrial driers and kilns complete the reaction.

This three-stage process can produce many types of ceramic powders. It is already being engineered, with industrial partners NORAM and BC Research, for high volume production and fast commercialization.

Nano One Materials has entered into a Joint Development Agreement with Saint-Gobain. The objective of this collaboration is to enhance high temperature processing of Nano One’s lithium ion battery materials. The two companies will work in collaboration, under the joint development agreement, to enhance the performance of its respective materials. Saint-Gobain produces a wide variety of construction and high-performance materials for applications in automotive, aerospace, health, and energy.

Nano One Materials has also entered into a Joint Development Agreement with Pulead Technology Industry. The Goal is to develop, evaluate, and optimize scaled up production of Pulead’s lithium iron phosphate (LFP) cathode materials utilizing Nano One’s technology, for use in lithium ion batteries. Licensing and commercialization opportunities will also be explored as part of this collaboration.

Last week, Dr. Stephen Campbell, CTO at Nano One Materials, announced the recent issuance of a patent in China. The Company now has 11 patents issued worldwide with Chinese patent ZL2014800279145 being directed to improved lithium ion batteries, using cathode materials made by Nano Ones’ patented process.

Dr. Stephen Campbell has been invited to speak at the Bank of Montreal’s 28th Global Metals and Mining Conference in Hollywood, Florida. Dr. Campbell will be speaking together with Kimberly Berman, BMO’s Special Projects Analyst specializing in battery chemistry, as part of the “Battery 101 – Intro to New Technology Session” in Ballroom C from 12:30pm – 1:30pm EST on Sunday, February 24, 2019. The session will introduce attendees to trends in lithium ion battery technology and raw materials.

Nano One Materials Corp. (NNOMF), closed Thursday's trading session at $1.0519, up 4.22%, on 21,947 volume with 33 trades. The average volume for the last 3 months is 14,686 and the stock's 52-week low/high is $0.7174/$1.50.

chart

The QualityStocks Company Corner

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) has signed a non-binding letter of intent, dated May 15, to acquire the branding asset package Soldaze from Santa Cruz, California-based Tres Ojos Naturals LLC. The move is part of TransCanna’s plan to put 15 premium cannabis brands on store shelves in the next 24 months, utilizing the company’s new 196,000-square-foot California facility as the hub for its operations. SolDaze produces cannabis-infused fruit snacks in California.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) brings together a rapidly growing portfolio of cannabis and hemp-related brands and services, with a closed-loop ecosystem approach rooted squarely in the company’s ownership of a 196,000-square-foot, vertically integrated facility in California. The company has developed a two-year, four-phase plan aimed at developing proprietary brands and creating a self-contained ecosystem that ensures reliability, consistency, quality and scale.

Ecosystem

TransCanna’s cannabis facility in Modesto, California, is strategically located less than a three-hour drive from the majority of all major cities in the state. The tri-level building provides internal control of everything needed for the seed-to-sale cycle, from growing and manufacturing to extraction, bottling, transportation and distribution. The facility, which recently went through an US$8 million renovation, is upgraded with a premium quality HVAC system and highly insulated roof to help reduce power costs, which already are some of the lowest in California.

The company has set 2020 goal for implementation of its full-service software platform, 420 Global, which will interact with every aspect of production flow, business development and the sales process.

Growing Portfolio

Acquisitions slated to be completed in June include Goodfellas Group LLC, a full-service advertising and marketing agency for the U.S. cannabis and hemp industries. Under the deal, TransCanna will also be acquiring Daily Cannabis Goods, a pre-rolled brand with nominal start-up costs and superior SKU velocity with cannabis products available at more than 30 dispensaries throughout California.

On Deck

The company has moved to acquire organic hemp-infused CBD coconut oil Biovelle (www.Biovelle.com). Biovelle is non-GMO, vegan and gluten free, with coconut sourced from plantations in the Philippines and American grown hemp from farms in Colorado.

TransCanna has also moved to further secure a growing foothold in cannabis edibles via a non-binding letter of intent with Persuasion Brewing Co., located near the company’s flagship facility in Modesto. The goal is to establish a Persuasion Brewing division at the main facility, which will produce a variety of different CBD infusion non-alcoholic beers.

Similarly, the company has recently executed a non-binding LOI with SolDaze (Tres Ojos Naturals, LLC) to gobble up the branding asset package of this California manufacturer of cannabis-infused fruit snacks (www.soldazesnacks.com).

Management

TransCanna’s management team consists of seasoned agriculture and consumer goods-oriented veterans.

Director, CEO and Chairman James Pakulis has 30 years of experience working with public and private entrepreneurial companies in a variety of emerging sectors. He has been on the front lines of the California cannabis industry for nearly a decade. He was CEO and chairman in 2010 of General Cannabis, Inc., which wholly owned the popular Weedmaps brand. Pakulis oversaw the growth of General Cannabis from pre-embryonic stages to over $16 million in revenue in less than two years, reaching a market cap of approximately $480 million.

Director and President Arni Johannson brings over 30 years of investing experience in the Canadian capital markets. He has built and or funded over 50 startups from around the world. He is president of Canadian Nexus Ventures and has been instrumental in providing guidance to pre- and post IPO companies, as well as guidance and oversight for corporate governance.

Stephen Giblin, board director, is an accomplished leader in the global hospitality, technology and real estate industries with a demonstrated track record of value creation. Juan Pablo Flores, independent director, is an attorney with more than 25 years of legal experience with a strong background in municipal, government, real estate, corporate and general civil law litigation.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $5.39, up 0.19%, on 39,810 volume with 61 trades. The average volume for the last 3 months is 159,420 and the stock's 52-week low/high is $0.769/$7.789.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) was featured today in the 420 with CNW by CannabisNewsWire. According to a notice published on Monday (June 3), Rhode Island hopes that blockchain technology can be harnessed to help the state to track medical marijuana and identify illegal actors. The state has called on blockchain technology developers to submit concepts from which the state will select a provider to develop a system that is customized for the medical marijuana program in Rhode Island.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $3.98, up 0.51%, on 23,188 volume with 144 trades. The average volume for the last 3 months is 44,703 and the stock's 52-week low/high is $3.75/$10.60.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile Inc. (TSX-V: SIM) (OTCQX: SYATF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities. To view the full publication, titled “FirstNet Public Safety Network, First-of-Kind Devices Meet Critical First-Responder Needs,” visit: http://nnw.fm/0ajeD.

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed the day's trading session at $0.3527, up 2.83%, on 415,284 volume with 51 trades. The average volume for the last 3 months is 64,337 and the stock's 52-week low/high is $0.254/$0.446.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ), a British Columbia-based company engaged in the business of acquisition, exploration and development of natural resource properties, is actively advancing its Irgon Lithium Mine. To view the full article, visit: http://nnw.fm/K3TrE.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.1559, up 3.93%, on 22,116 volume with 15 trades. The average volume for the last 3 months is 55,329 and the stock's 52-week low/high is $0.1155/$0.4289.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

Innovative technology holding company VPR Brands LP (OTC: VPRB) released the results of fiscal operations for first quarter 2019. Among other highlights, the company reported continually increasing revenues and a narrowing net loss. To view the full article, visit: http://nnw.fm/Bsv7P.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed the day's trading session at $0.0571, up 2.33%, on 34,784 volume with 8 trades. The average volume for the last 3 months is 80,359 and the stock's 52-week low/high is $0.026/$0.1397.

Recent News

chart

Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software Inc. (OTC: PFSF) (“Pacific Software” or the “Company”) today announces that it has entered into a Memorandum of Understanding (MOU) with Império Assessoria em Informaçoes LTDA (Império) located in Sao Paulo, Brazil. Pursuant to the MOU, the parties agree to commercially market and promote the activities of the commodities trade portal BOAPIN.com powered by Pacific Software and Atlas Cargo Suite, an agribusiness, logistics management software module owned and operated by Império.

Pacific Software, Inc. (PFSF) is an emerging technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms. The company is building “BoaPin,” a subscription-based e-commerce trading platform focused on cross border trade expansion with an international emphasis. The multi-faceted e-commerce platform is scheduled for launch in Q1 of 2019.

The Company is uniquely positioned to deliver a B2B and B2C intelligent e-commerce trade platform which will provide various solutions, data, applications and tools for subscribers, including IBM’s Hyperledger Blockchain “Backend as a Service” (BaaS) Infrastructure, multi-lingual communication, fintech, digital marketing, smart contracts, commodities search/match applications, customs clearance, taxation data, product advertising and logistics solutions.

Through smart contract technology for global supply chain management, BoaPin is designed to improve product traceability and deliver solutions to its subscribers for product certification, marketing, logistics, commodities search/match interface, trade finance, cross border payment solutions and customs clearance. Some of the tools available to execute these capabilities include cross border payments, blockchain solutions, smart contracts and multilingual access.

With these features at hand, the company is targeting several key industries where its online applications and solutions could have significant corporate impact in various forms, including: agriculture, fertilizers, chemicals, cosmetics, electronics, equipment, apparel and controlled substance management.

Business Model

Pacific Software initially will focus on Brazil and China for BoaPin. After paying a registration fee to utilize the online trade portal, subscribers to the platform will have access to a variety of tools and features that may enhance and increase revenue initiatives by showcasing their commodities and products for sale or trade.

Buyers of the commodities, products or services will pay a transaction fee only to the company which could materialize in the form of cash, cash equivalents, royalties or in-kind fees.

As the company executes its strategy, the online trade business is anticipated to generate significant revenue from subscribers obtained from regionally and federally organized Brazilian Trade Associations. The members wish to market their commodities or products, and the portal users or buyers materialize from China, Hong Kong and surrounding countries. As a result, this business model may be organized separately in the company’s wholly owned subsidiary, incorporated as HyperSoft Ventures, which could generate appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $4.50, even for the day. The stock's 52-week low/high is $2.00/$5.50.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Geyser Brands Inc. (TSX.V: GYSR) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication, titled “Products for Pets Gain Prominence in Hemp Market,” please visit: http://cnw.fm/F2jFi.

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed the day's trading session at $0.65, even for the day, on 3,000 volume. The average volume for the last 3 months is 8,977 and the stock's 52-week low/high is $0.55/$0.85.

Recent News

chart

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) was featured today in the 420 with CNW by CannabisNewsWire. Developing new technologies to track cannabis sales has taken on an increasing level of urgency given that financial institutions are reluctant to work with marijuana businesses for fear that the federal government will take enforcement action against them. A reliable tracking system can provide assurance that only state-legal marijuana is passing through the system, and this can provide a basis for banks and other institutions to defend themselves.

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed the day's trading session at $7.21, off by 1.64%, on 528,006 volume with 2,027 trades. The average volume for the last 3 months is 1,228,563 and the stock's 52-week low/high is $2.97/$8.44.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company in the U.S., this morning announced that it has qualified to trade on the OTCQX Best Market and will begin trading today, June 6, 2019, under the symbol “PLPRF.” The company’s shares will continue to trade under the symbol “PLUS” on the Canadian Securities Exchange. Also today, the company announced that it has acquired an option to purchase Emerald Bay Wellness LLC, a California-based cannabis oil manufacturer. The option grants PLUS the irrevocable right, but not the obligation, to purchase all of the business assets of Emerald Bay Extracts for cash and stock consideration. Additionally, the company was highlighted in an article examining how, later this year another large legal cannabis market will open up, with the lifting of prohibition on edibles and extracts in Canada. Following in the footsteps of larger markets, such as California, Canada is about to experience a heavier strain on supplies , as producers struggle to meet demand, particularly with the capability to yield extracts needed for these new products.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $3.11, off by 4.31%, on 22,058 volume with 84 trades. The average volume for the last 3 months is 75,657 and the stock's 52-week low/high is $2.81/$6.01.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted today in a publication from Financialnewsmedia.com, examining how, according to a recent industry article published this year, Jefferies analysts, after initiating coverage on the cannabis markets , followed up with additional coverage specific to the CBD industry and in particular CBD beauty products.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $2.5488, off by 2.59%, on 153,586 volume with 280 trades. The average volume for the last 3 months is 261,662 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) patented DehydraTECH delivery technology has demonstrated in animal lab tests that it can deliver cannabinoids to the bloodstream more quickly than conventional cannabinoid formulations (http://nnw.fm/fsKW4). At 15 minutes into the test, the DehydraTECH formulation achieved a blood concentration level that was 475 percent higher than a generic coconut oil formulation; at 60 minutes, the blood concentration level was 319 percent higher.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $0.8718, off by 0.93%, on 114,951 volume with 96 trades. The average volume for the last 3 months is 105,168 and the stock's 52-week low/high is $0.75/$2.43.

Recent News

chart

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P)

The QualityStocks Daily Newsletter would like to spotlight Nabis Holdings (OTC: INNPF).

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) was reported among the presentations for the latest batch of VICs. Virtual Investor Conferences and KCSA Strategic Communications today announced that the presentations from the June 4th Cannabis Industry Virtual lnvestor Conference are now available for on-demand viewing at VirtualInvestorConferences.com. Log in to view the presentations now:  https://tinyurl.com/June4CannabisVIC.

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."

Strategy

While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.

Criteria for investment targets are as follows:

  • Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
  • Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
  • Identifying proven operators with good expertise to add value to a consolidation strategy
  • Focused on MSOs (Multi-state Operators) with strong brand traction
  • Pharma grade cultivation, extraction, dispensaries and other addressable operations

Current Endeavors

Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.

Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.

Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.

Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.

Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.

Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.

Proven Management Team

CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.

President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.

Nabis Holdings (OTC: INNPF), closed the day's trading session at $0.4244, off by 5.63%, on 14,830 volume with 19 trades. The average volume for the last 3 months is 182,051 and the stock's 52-week low/high is $0.392/$0.791.

Recent News

chart

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE), a Canada-based exploration company, this morning announced the beginning of phase two drilling at its flagship Cyclops nickel-cobalt development project in Indonesia. To view the full press release, visit: http://nnw.fm/2Qzf9.

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed the day's trading session at $0.11429, off by 5.47%, on 20,000 volume with 11 trades. The average volume for the last 3 months is 26,748 and the stock's 52-week low/high is $0.07/$0.378.

Recent News

chart

Endonovo Therapeutics Inc. (ENDV)

The QualityStocks Daily Newsletter would like to spotlight Endonovo Therapeutics Inc. (ENDV).

Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. A recent article discussing the company reads, “Endonovo Therapeutics develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. To view the full article, visit: http://nnw.fm/T7FSm.

Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.

In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.

Flagship Therapy

SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s?targeted?pulsed electromagnetic field?(tPEMF)?transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.?

Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.

Certifications

Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.

Management

Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.

Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.?

Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.

Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.

Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.

David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.

Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.

Endonovo Therapeutics Inc. (ENDV), closed the day's trading session at $0.01217, off by 2.64%, on 3,337,697 volume with 55 trades. The average volume for the last 3 months is 2,640,540 and the stock's 52-week low/high is $0.0089/$0.066.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.